Last kr264.00 DKK
Change Today 0.00 / 0.00%
Volume 260.3K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Copenhagen
Frankfurt
As of 11:02 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kurt Anker Nielsen M.Com.

Former Vice Chairman of the Board and Chairman of Audit Committee, Novozymes A/S
AgeTotal Calculated CompensationThis person is connected to 11 board members in 2 different organizations across 13 different industries.

See Board Relationships
69kr200,000

Background*

Mr. Kurt Anker Nielsen, M.Com., served as Co-President and Chief Executive Officer of Novo A/S. He served as a Co-Chief Executive Officer of Novo A/S from December 2000 to September 2003. From 1996 to December 2000, he served as the Deputy Chief Executive Officer of Novo Nordisk A/S and also served as its Managing Director. From 1989 to December 2000, he served as the Chief Financial Officer of Novo Nordisk A/S; Executive Vice President of Corporate Finance from 1985 ...

Read Full Background

Corporate Headquarters*

Krogshoejvej 36
Bagsvaerd, -- 2880

Denmark

Phone: 45 44 46 00 00
Fax: 45 44 46 99 99

Board Members Memberships*

Former Director
Director
Director
Co-Chief Executive Officer and Director
1997-N/A
Former Director, Chairman of Audit Committee and Chairman of Nominating & Corporate Governance Committee
2000-2013
Former Director, Member of Audit Committee and Chief Executive Officer of Novo A/S
2000-2014
Former Vice Chairman of the Board and Chairman of Audit Committee
2000-N/A
Former Vice Chairman
2003-2006
Former Director
2004-2007
Former Director and Chairman of Audit Committee
2006-N/A
Former Director and Chairman of Audit Committee
2006-2013
Former Director and Chairman of Audit Committee
2007-2009
Former Director and Chairman of Audit Committee

Education*

MS 1972
Copenhagen Business School
BA
Copenhagen Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensationkr200,000
Total Calculated Compensationkr200,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr264.00 DKK 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
4.4M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.